1. Home
  2. CRESY vs ABUS Comparison

CRESY vs ABUS Comparison

Compare CRESY & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cresud S.A.C.I.F. y A.

CRESY

Cresud S.A.C.I.F. y A.

HOLD

Current Price

$11.68

Market Cap

713.6M

Sector

Finance

ML Signal

HOLD

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.61

Market Cap

848.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRESY
ABUS
Founded
1936
2005
Country
Argentina
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
713.6M
848.1M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
CRESY
ABUS
Price
$11.68
$4.61
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
226.4K
1.0M
Earning Date
11-10-2025
11-13-2025
Dividend Yield
7.94%
N/A
EPS Growth
N/A
N/A
EPS
0.18
N/A
Revenue
$702,652,598.00
$14,606,000.00
Revenue This Year
N/A
$125.30
Revenue Next Year
N/A
N/A
P/E Ratio
$6.20
N/A
Revenue Growth
N/A
116.64
52 Week Low
$8.39
$2.71
52 Week High
$14.23
$5.10

Technical Indicators

Market Signals
Indicator
CRESY
ABUS
Relative Strength Index (RSI) 53.48 55.81
Support Level $11.23 $4.09
Resistance Level $12.10 $4.63
Average True Range (ATR) 0.55 0.19
MACD -0.08 0.02
Stochastic Oscillator 46.84 90.00

Price Performance

Historical Comparison
CRESY
ABUS

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is a Latin American agricultural firm producing basic commodities with a growing presence in Argentina, Brazil, and other countries through its investment in Brasilagro. It focuses on grains, sugarcane, and cattle farming, acquiring and developing agricultural properties for production or value appreciation, and occasionally selling appreciated land. It also leases land and offers agency and agro-industrial services. Operations are divided into two segments: agricultural business (production, land transformation and sales, corporate services) and urban properties and investments (shopping malls, offices, sales, developments, hotels, and related activities).

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: